All Articles

U.S. sugar demand remains surprisingly strong, but a perfect storm of health trends and weight-loss drugs like Ozempic threatens a $55 billion upheaval.

A new Premier Inc. designation gives BRIJ Medical vast market access for its hypoallergenic BRIJ-SEAL, signaling a shift in post-operative care standards.

A new Pet Supplies Plus in Queen Creek promises a neighborhood feel. But as giant franchises move in, can a corporate playbook deliver a genuine local touch?

With a 14.5% profit surge, Renault's finance arm proves its resilience, driving EV adoption and redefining ownership in a volatile automotive market.

Edison Insurance's 9.8% rate cut is more than homeowner relief. It’s a strategic play proving Florida's aggressive reforms are paying dividends and reshaping the market.

With a new CEO for operations and an Executive Chairman for M&A, Kalon Aesthetics is executing a playbook aimed at rapid consolidation in the booming aesthetics market.

With its Summer 2026 release, Zywave is betting on 'agentic AI' to automate admin tasks, freeing brokers to become the strategic advisors clients need.

For America's 250th, archivists and tech firm Preservica are building a digital ark, ensuring the nation's diverse, complex history survives for generations.

Gartner's new Magic Quadrant for DTOs signals a market shift. As firms like ARIS lead, we analyze why this virtual blueprint is now non-negotiable.

As Vuzix prepares its Q2 2026 earnings call, investors will look past the numbers to a bigger question: can its pivot to an OEM model unlock its AR potential?

Kioxia's new CM10 SSDs bring PCIe 6.0 speed and liquid cooling to data centers, directly tackling the immense data demands of tomorrow's AI models.

Data I/O reports a 59% sequential sales jump, but a surprise delay in its full earnings to analyze a complex $9M investment introduces critical uncertainty.

With strong H1 growth, heritage manager Kaleon isn't just polishing its family-owned gems. A new third-party deal and bold financial moves signal a strategic pivot.

Autism care provider BlueSprig made TIME's new 'Best Private Companies' list. The real story is how it reveals a new metric for success beyond profit.

How a travel company’s annual charity day reveals a deeper strategy of building permanent value by transforming consumer transactions into resilient social impact.

A $3.5M investment brings a proven nonprofit ISP model from Cleveland to Detroit, aiming to rewire the city's approach to digital equity. Is this the fix?

TekSynap's appointment of Brent Newman signals a critical shift: in an era of intense competition for cleared talent, human capital is the ultimate mission asset.

Karyopharm's stock plummets after a key cancer trial fails, forcing a strategic retreat and a hard pivot toward more promising assets in its pipeline.

With a new $300M+ funding round, Xsight Labs is challenging giants like NVIDIA by championing open, programmable hardware for next-gen data centers.

Trench Group's new $60M Charlotte plant isn't just making parts; it's forging resilience for a U.S. power grid facing an unprecedented megawatt surge.